- Home
- / Evolutionary Genomics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Evolutionary Genomics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0
2024-10-28
Market Capitalization
$5.3 K
2024-10-28
Revenue
$12.5 K
FY, 2020
CreditSafe Score
?
Score changed on Jun 04, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2011 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 262.9K | 221.6K | 32.7K | 114.8K | 122.7K | 12.5K | |||||
| Cost of goods sold | 146.6K | ||||||||||
| Gross profit | 116.3K | ||||||||||
| Gross profit margin, % | 44.3% | ||||||||||
| General and administrative expense | 294.1K | 290.8K | 271.4K | 229.0K | 219.1K | 603.6K | 1.3M | 1.3M | |||
| Operating expense total | 839.2K | 1.0M | 1.1M | 703.0K | 691.7K | 2.4M | 1.7M | ||||
| EBIT | (17.3K) | (14.6K) | (24.5K) | (722.9K) | (1.1M) | (1.3M) | (836.8K) | (774.8K) | (2.9M) | (2.9M) | (2.0M) |
| EBIT margin, % | -274.9% | -475.4% | -3984.8% | -728.8% | -631.6% | -23038.4% | |||||
| Interest income | 57.0 | 7.4K | 6.4K | 694.0 | 98.0 | 372.0 | 604.0 | 1.3K | |||
| Interest expense | 4.7K | 2.6K | 436.9K | 98.6K | 232.8K | 261.8K | |||||
| Pre tax profit | (1.1M) | (1.1M) | (761.2K) | (2.7M) | (2.8M) | (1.9M) | |||||
| Income tax expense | (530.2K) | 31.9K | (987.4K) | ||||||||
| Net Income | (17.3K) | (19.3K) | (27.1K) | (286.0K) | (1.2M) | (539.6K) | (1.1M) | (793.1K) | (1.7M) | (2.8M) | (1.9M) |
| EPS | (0.3) |